Grantclosed🌐 United StatesRFA-DK-26-306

Engineering Improved Stem Cell-Derived Islet Cells for Replacement Therapies (R01 - Clinical Trial Not Allowed)

National Institutes of Health

Details?

Posted: Dec 3, 2025
Response deadline: Mar 7, 2026, 12:00 AM UTC
Type: Grant
Category: 93.847
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: RFA-DK-26-306

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Engineering Improved Stem Cell-Derived Islet Cells for Replacement Therapies
United States · Jun 13, 2025
Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)
United States · Dec 2, 2024
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed)
United States · Nov 6, 2024
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed)
United States · Aug 14, 2024
Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
United States · Jan 15, 2025
Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
United States · Dec 9, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.